Taken together, the clinical data suggest a correlation of the expression of the IL-10/IL-10RA axis and CSF1R and an association of the IL-10highCSF1Rlow profile with an immunostimulatory signature and favorable prognosis of patients with HNSCC. The gene discussed is CSF1R; the disease is head and neck squamous cell carcinoma.